Business
PharmaCielo Becomes First Cultivator Awarded Good Agricultural Practices (GAP) Global Certification for Colombian Medicinal-Cannabis Operations
PharmaCielo Becomes First Cultivator Awarded Good Agricultural Practices (GAP) Global Cert...
About this update from Pharmacielo Ltd.
[{"type":"text","content":"\n\n\n\nPharmaCielo Becomes First Cultivator Awarded Good Agricultural Practices (GAP) Global Certification for Colombian Medicinal-Cannabis Operations\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nTORONTO and RIONEGRO, Colombia, Jan. 20, 2020\n\n\n\nPharmaCielo is the first cannabis cultivator evaluated by Swiss founded SGS to meet international certification standards Good Agricultural Practices (GAP) certification testament to safe and sustainable cultivation practices; supportive of Good Manufacturing Practices (GMP) designation continuum and international market sales GAP skill set evidenced by cultivar registration of additional 10 unique strains; total of 30 unique and proprietary strains now registered for commercial use TORONTO and RIONEGRO, Colombia, Jan. 20, 2020 /CNW/ - PharmaCielo Ltd. (\"PharmaCielo\" or the \"Company\") (TSXV: PCLO, OTCQX: PCLOF), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis extracts, PharmaCielo Colombia Holdings S.A.S., is pleased to announce that the Company has received the global Good Agricultural Practices (GAP) certification for its propagation, flowering and medical cannabis production operations in Colombia.\n\n \n \n\n \n\"The GAP certification attests our commitment and best practices that we deploy in the production of the highest-quality medicinal-cannabis extracts while adhering to the most stringent international safety, environmental and regulatory standards,\" said David Attard, CEO at PharmaCielo Ltd. \"Receipt of Certificate #001, which is the first granted in the cannabis industry, is an important step and provides PharmaCielo with a competitive advantage in supporting export opportunities for our high-quality medicinal-grade extracts into international markets where such accreditation is required.\"\nThe GAP certification awarded to PharmaCielo followed a rigorous evaluation of 276 parameters to ensure full compliance with the global standard. The evaluation took a full year to complete and included monitoring and evaluation of the Company's pro...